MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Drops

国药准字H20223143

March 16, 2022

Drug Information

盐酸左西替利嗪口服滴剂

口服溶液剂

10ml:50mg

化学药品

March 16, 2022

Company Information

Applicant Company

安徽省合肥市肥西县经济开发区文山路10号

Manufacturing Company

安徽省合肥市经开区桃花工业园文山路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服滴剂 - NMPA 批准文号 | MedPath